RxDoctor Payments Data

Mark Schreiber, MD

Psychiatry · Virginia Beach, VANPI 1124090022

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.9%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 67.5% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2020 at $9,903 and has fallen 82.4% since, to $1,747 in 2025. Among psychiatry clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,143in general payments, 2019–2025

Across 673 payments — averaging $43.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$20K
  • Johnson & Johnson$2K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$881
  • Sunovion Pharmaceuticals Inc.$807
  • plus $4K from 29 others

What the payments were for

  • Speaking & faculty fees$16,28056%
  • Travel & lodging$720%
  • Food & beverage$12,63343%
  • Education$1581%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,143 in reported general payments places this provider in the 95th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$76,127
Medicare patients
193
Services billed
749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate11$92,094
RexultiBrexpiprazole32$68,449
VraylarCariprazine Hcl40$57,367
TrintellixVortioxetine Hydrobromide33$28,549
Lamictal XrLamotrigine13$23,953
Invega SustennaPaliperidone Palmitate11$22,108
Aripiprazole189$14,438
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine69$5,973
Duloxetine Hcl257$5,410
Desvenlafaxine Succinate ErDesvenlafaxine Succinate64$5,211
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine116$4,839
Atomoxetine Hcl35$4,340
Quetiapine Fumarate226$3,773
Lurasidone Hcl15$3,771
Clomipramine Hcl15$3,764

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$379$92,09411 claims
Otsuka America Pharmaceutical, Inc.Rexulti$1,312$68,44932 claims
AbbVieVraylar$19,683$57,36740 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$213$28,54933 claims
Johnson & JohnsonInvega Sustenna$1,502$22,10811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →